#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults
Breakpoints - A podcast by Society of Infectious Diseases Pharmacists
Episode Notes
Drs. Ann Falsey, Crystal Hodge (@Howzzeee) and Michael Ison (@MichaelGIsonMD) join Dr. Jillian Hayes (@thejillianhayes) for a review of non-COVID respiratory viruses. Tune in for a review of current epidemiological changes, the vaccine pipeline, and current treatment options. This episode was supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp References- Community-acquired respiratory viruses in transplant patients (PMID 31511250)
- Clinical Transplantation 2019 special issue on Transplant Infectious Diseases Guidelines: ](https://urldefense.com/v3/https:/onlinelibrary.wiley.com/toc/13990012/2019/33/9;!!OToaGQ!ujpO69U-82gjgidcyi6YshodQ4umKoYBRbC6wcHf-7QtOVoXotlCzZSwBl7eXjGal8O6D5qQIF8k7_GUOsi3weedNyWNXbw$)[https://onlinelibrary.wiley.com/toc/13990012/2019/33/9
- ECIL-4 Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus https://doi.org/10.1093/cid/cis844
- JID RSV Supplements: https://academic.oup.com/jid/issue/226/Supplement_1, https://academic.oup.com/jid/issue/226/Supplement_2
- CID Precision Vaccinology Supplement: https://academic.oup.com/cid/issue/75/Supplement_1
- Net State of Immunosuppression (PMID 32803228)
- Inflammatory and Infectious Syndromes Associated With Cancer Immunotherapies (PMID 30520987)
- Biologic response modifiers (PMID 28263774)
- Invasive fungal infections and targeted therapies in hematologic malignancies (PMID 34947040)
- Impact of COVID-19 on Influenza vaccination strategies (PMID 35607766)
- Zanamivir vs oseltamivir (PMID 35299245)
- Peramivir vs oseltamivir (PMIDs 33447633, 33006445)
- FLAGSTONE (PMID 35085510)
- CAPSTONE-2 (PMID 32526195)
- Neuraminidase inhibitor benefits beyond 48 hours (PMID 33434667, 32898685, 24815805, 24268590)
- Baloxavir for prophylaxis of household contacts (PMID 32640124)
- Oral ribavirin for RSV in HCT (PMID 30202920)
- Ribavirin for RSV and human metapneumovirus in HCT (PMID 32162389)
- DAS181 for parainfluenza virus (PMID 33569576)
